• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT CA 125 II; OC 125 DEFINED ANTIGEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT CA 125 II; OC 125 DEFINED ANTIGEN Back to Search Results
Catalog Number 02K45-25
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
The customer reports that an aliquot of one patient's sample was taken from the initial collection tube and tested with the architect ca125 ii assay on an architect i2000 analyzer (sn (b)(4)).Results of 159.5 and 156.3 u/ml were generated with reagent lot 39018m500.The aliquot was recentrifuged and tested on a second architect i2000 analyzer (sn (b)(4)) and generated results of 23.0 and 23.3u/ml with reagent lot 41540m500.This is the only patient sample to exhibit this phenomenon.There were no significant differences in calibration curves between the two analyzers.The sample was sent to a reference lab.A result of 160.8 u/ml was generated on an architect isystem using reagent lot 39018m500 and a result of 20.5 u/ml was generated with lot 41540m500.A dilution study was also performed (reagent lot 39018m500) with the following results: 1:2 = 249.6 u/ml; 1:4 = 326.4 u/ml; 1:8 = 375.2 u/ml; 1:16 = 387.2; 1:32 = 284.8 u/ml.Treatment of the sample with a heterophilic antibody: treated = 10.7 u/ml and untreated = 6.7 u/ml.There is no impact to patient management reported.
 
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.(b)(4).
 
Manufacturer Narrative
There were no returns available from the customer site for this evaluation.Accuracy testing was performed using an in-house retained reagent kit of lot 39018m500.One isystem analyzer was successfully calibrated and replicates of a ca 125 panel set (1 - 3) were tested.All results met acceptance specifications, indicating acceptable performance of the assay lot.The architect ca125 ii assay package insert contains information to address the current customer issue.A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation.Based on the available information from the customer site and from the results of this evaluation, there is no evidence to reasonably suggest a product malfunction occurred.The issue was confined to one discreet patient sample, which further evaluation by the customer indicated the presence of a heterophilic antibody.No additional issues were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT CA 125 II
Type of Device
OC 125 DEFINED ANTIGEN
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 350
Manufacturer (Section G)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 350
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key4585997
MDR Text Key18027565
Report Number1415939-2015-00003
Device Sequence Number1
Product Code LTK
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K042731
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/18/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/10/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/04/2015
Device Catalogue Number02K45-25
Device Lot Number39018M500
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/12/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/01/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000 ANALYZER LN: 08C89-01; (B)(4); (B)(4); ARCHITECT I2000 ANALYZER LN: 08C89-01
-
-